Harry Alcorn Jr Net Worth & Insider Trades
Harry Alcorn Jr - SVP, Diamedica Therapeutics Inc
What is Harry Alcorn Jr's Net Worth?
The current estimated net worth of Diamedica Therapeutics Inc's SVP, Harry Alcorn Jr, is estimated to be about $75.21K . Harry Alcorn Jr owns about 43,981 units of Diamedica Therapeutics Inc common stock. In the last 3 years at Diamedica Therapeutics Inc, Harry Alcorn Jr has sold an estimated value of $0 worth.
What is Harry Alcorn Jr's Past Insider Trading?
Harry Alcorn Jr's largest purchase order was 20,721 units , worth over $64.05K on August 16, 2021. In total, Harry Alcorn Jr has made about 8 transactions over 3 years of their time at Diamedica Therapeutics Inc. Harry Alcorn Jr usually trades in June and August, with the busiest year in 2019 and 2021. The most recent transaction was a purchase order of 15,000 units , worth over $56.96K on September 15, 2021.
HARRY ALCORN JR
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Harry Alcorn Jr's Salary in 2020?
As SVP of Diamedica Therapeutics Inc, Harry Alcorn Jr has a total base salary of $291,413 . Harry Alcorn Jr received compensation valued at about $509,065 in 2020 after becoming SVP. The vast majority of their compensation came in the form of option awards of $119,140 , other earnings, plans or compensations of $83,662 , and other compensation of $14,850 .
What is Harry Alcorn Jr's' Mailing Address?
- Mailing address is 2 Carlson Parkway Suite 260 Minneapolis MN 55447 MN
Diamedica Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Rick Pauls | 2020 | $455,013 | - | $190,624 | $217,716 | $14,850 | $878,203 |
| Rick Pauls | 2019 | $420,000 | - | $890,736 | $178,000 | $14,650 | $733,707 |
| Scott Kellen | 2020 | $276,075 | - | $119,140 | $79,238 | $14,850 | $489,303 |
| Scott Kellen | 2019 | $262,500 | - | $336,557 | $64,800 | $13,950 | $677,807 |
| Harry Alcorn, Jr., Pharm.D. | 2020 | $291,413 | - | $119,140 | $83,662 | $14,850 | $509,065 |
| Harry Alcorn, Jr., Pharm.D. | 2019 | $273,750 | - | $421,750 | $68,400 | $14,400 | $778,300 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm
What are Diamedica Therapeutics Inc's Past Insider Trades?
Diamedica Therapeutics Inc's most recent insider trade came on April 11, 2023 by David Wambeke who bought 468,750 units worth $750K . In the last 5 years, insiders at Diamedica Therapeutics Inc have sold an estimated value of $3.53M and bought an estimated value of $6.28M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Michael Randall Giuffre, Director, Richard Pilnik, Director, and Scott Kellen, CFO and Secretary .
DiaMedica Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||